ArriVent BioPharma (AVBP) Stock
ArriVent BioPharma (AVBP) closed at $10.69 on Nov 17, 2026; its Tenet Score is 69 of 100 against 340 Healthcare peers.
37 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $10.69
- Nov 17, 2026
- Market cap
- $572.5M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 11.36 – 35.83
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 69/100
- Solid · 340 Healthcare peers
Industry: Pharmaceutical Preparations
ArriVent BioPharma Inc. scores 69/100. Solid. Strongest on value and financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 69 is built from 3 of 4 pillars, from 30% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Quality Floor
- ~ Qualified Dip
13F flows & insider trades land here.
We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. We seek to utilize our team’s deep drug development…
Similar-sized companies in Pharmaceutical Preparations
The 8 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| MBX Biosciences Inc.MBX | 53 | $2.6B |
| Septerna Inc.SEPN | 54 | $2.0B |
| Zenas Biopharma Inc.ZBIO | 29 | $1.8B |
| Rapport Therapeutics Inc.RAPP | 59 | $1.5B |
| Alto Neuroscience Inc.ANRO | 53 | $1.1B |
| Alumis Inc.ALMS | 56 | $667.3M |
| Bicara Therapeutics Inc.BCAX | 61 | $666.7M |
| BioAge Labs Inc.BIOA | 74 | $239.7M |
Common questions
What sector and industry is ArriVent BioPharma in?
ArriVent BioPharma is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is ArriVent BioPharma's Tenet Score?
ArriVent BioPharma's Tenet Score is 69 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




